Cargando…
Correction to: Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies
Autores principales: | D’Amico, Adele, Longo, Antonella, Fattori, Fabiana, Tosi, Michele, Bosco, Luca, Testa, Maria Beatrice Chiarini, Paglietti, Maria Giovanna, Cherchi, Claudio, Carlesi, Adelina, Mizzoni, Irene, Bertini, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764784/ https://www.ncbi.nlm.nih.gov/pubmed/35039067 http://dx.doi.org/10.1186/s13023-021-02171-y |
Ejemplares similares
-
Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies
por: D’Amico, Adele, et al.
Publicado: (2021) -
Switching therapies: safety profile of Onasemnogene abeparvovec-xioi in a SMA1 patient previously treated with Risdiplam
por: Tosi, Michele, et al.
Publicado: (2022) -
How the Management of Children With Congenital Central Hypoventilation Syndrome Has Changed Over Time: Two Decades of Experience From an Italian Center
por: Porcaro, Federica, et al.
Publicado: (2021) -
Novel Splicing Mutation in MTM1 Leading to Two Abnormal Transcripts Causes Severe Myotubular Myopathy
por: Bosco, Luca, et al.
Publicado: (2022) -
All You Need Is Evidence: What We Know About Pneumonia in Children With Neuromuscular Diseases
por: Cherchi, Claudio, et al.
Publicado: (2021)